The effect of parenteral lipid emulsions on pulmonary hemodynamics and eicosanoid metabolites in preterm infants: a pilot study.

BACKGROUND Soy-based intravenous fat emulsion (IVFE) is known to cause a rise in pulmonary artery pressure in the preterm infant, thought to be mediated through eicosanoid metabolites of linoleic acid. We compared the effect of soy-based IVFE and an olive-oil-based IVFE containing less than half the content of linoleic acid on pulmonary artery pressure and eicosanoid metabolites in preterm infants receiving parenteral nutrition. METHODS In this pilot study at a regional neonatal intensive care unit (ICU), infants received either a soy-based or olive-oil-based IVFE as part of an otherwise identical feeding protocol. Pulmonary artery pressure and urinary thromboxane B2 and prostaglandin F1 alpha were measured at baseline and maximum lipid infusion. RESULTS There was a greater fall in pulmonary artery pressure in the olive-oil-based IVFE group compared with the soy-based IVFE group. A decrease in urine thromboxane/prostaglandin F1 alpha ratio was seen only in the olive-oil-based IVFE group. CONCLUSIONS In the parenterally fed preterm infant, an olive-oil-based IVFE may have a beneficial effect on pulmonary artery pressure when compared with soy-based IVFE. Effects on pulmonary vascular tone are likely to be mediated through alterations in eicosanoid metabolism. A randomized trial is warranted to compare the effects of different lipid emulsions.

[1]  M. Campbell,et al.  What is a pilot or feasibility study? A review of current practice and editorial policy , 2010, BMC medical research methodology.

[2]  P. Singer,et al.  Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions , 2010, Intensive Care Medicine.

[3]  B. Koletzko,et al.  ESPGHAN and ESPEN Guidelines Paediatric Parenteral Nutrition - Annex: List of Products , 2005, Journal of pediatric gastroenterology and nutrition.

[4]  B. Koletzko,et al.  Parenteral Fat Emulsions Based on Olive and Soybean Oils: A Randomized Clinical Trial in Preterm Infants , 2003, Journal of pediatric gastroenterology and nutrition.

[5]  V. Vital-reyes,et al.  Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia. , 2003, American journal of obstetrics and gynecology.

[6]  N. Marlow,et al.  High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. , 2002, The New England journal of medicine.

[7]  S. Abman.  Monitoring cardiovascular function in infants with chronic lung disease of prematurity , 2002, Archives of disease in childhood. Fetal and neonatal edition.

[8]  G. Béréziat,et al.  Long-term efficacy and safety of a new olive oil-based intravenous fat emulsion in pediatric patients: a double-blind randomized study. , 1999, The American journal of clinical nutrition.

[9]  G. Kostopanagiotou,et al.  Long chain versus medium chain lipids in patients with ARDS: effects on pulmonary haemodynamics and gas exchange , 1998, Intensive Care Medicine.

[10]  J. Skinner,et al.  Estimation of Pulmonary Arterial Pressure in the Newborn: Study of the Repeatability of Four Doppler Echocardiographic Techniques , 1996, Pediatric Cardiology.

[11]  J. Van Aerde,et al.  Pulmonary vascular resistance during lipid infusion in neonates. , 1996, Archives of disease in childhood. Fetal and neonatal edition.

[12]  R. Cooke.  Factors associated with chronic lung disease in preterm infants. , 1991, Archives of disease in childhood.

[13]  D. Rushton,et al.  Pulmonary intravascular lipid in neonatal necropsy specimens. , 1991, Archives of disease in childhood.

[14]  M. F. Chen,et al.  Effects of intravenous fat emulsion on respiratory failure. , 1990, Chest.

[15]  C. Hammerman,et al.  Intravenous lipids in newborn lungs: thromboxane-mediated effects. , 1989, Critical care medicine.

[16]  C. Hammerman,et al.  Decreased lipid intake reduces morbidity in sick premature neonates. , 1988, The Journal of pediatrics.

[17]  R. Smith,et al.  Cardiopulmonary effects of Intralipid infusion in critically ill patients. , 1988, Critical care medicine.

[18]  W. Teague,et al.  Lung Vascular Effects of Lipid Infusion in Awake Lambs , 1987, Pediatric Research.

[19]  S. Goldberg,et al.  Doppler echocardiographic prediction of pulmonary arterial hypertension in congenital heart disease. , 1984, The American journal of cardiology.

[20]  R. Traystman,et al.  Oxidant- and lipid-induced pulmonary vasoconstriction mediated by arachidonic acid metabolites. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[21]  B. Dahms,et al.  Pulmonary arterial lipid deposit in newborn infants receiving intravenous lipid infusion. , 1980, The Journal of pediatrics.

[22]  C. Stanley,et al.  Decreased oxygenation and hyperlipemia during intravenous fat infusions in premature infants. , 1980, Pediatrics.

[23]  D. Richardson,et al.  Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. , 1998, The Pediatric infectious disease journal.

[24]  M. Boucek,et al.  Effect of intralipid on the neonatal pulmonary bed: an echographic study. , 1986, The Journal of pediatrics.

[25]  S. C. Sun,et al.  Effect of Intralipid-induced lipaemia on the arterial oxygen tension in preterm infants. , 1978, Resuscitation.